1 Introduction 5
1.1 Industry Definition and Research Scope 5
1.1.1 Industry Definition 5
1.1.2 Research Scope 7
1.2 Research Methodology 9
1.2.1 Overview of Market Research Methodology 9
1.2.2 Market Assumption 10
1.2.3 Secondary Data 10
1.2.4 Primary Data 10
1.2.5 Data Filtration and Model Design 11
1.2.6 Market Size/Share Estimation 12
1.2.7 Research Limitations 13
1.3 Executive Summary 14
2 Market Overview and Dynamics 16
2.1 Market Size and Forecast 16
2.1.1 Impact of COVID-19 on World Economy 17
2.1.2 Impact of COVID-19 on the Market 19
2.2 Major Growth Drivers 21
2.3 Market Restraints and Challenges 26
2.4 Emerging Opportunities and Market Trends 29
2.5 Porters Fiver Forces Analysis 33
3 Technology of Neurology Robotic Surgery 37
3.1 Stereotactic Biopsy 39
3.2 Craniotomy 40
3.3 Shunt 41
3.4 Deep Brain Stimulation 42
4 Segmentation of Asia Pacific Market by Product 43
4.1 Market Overview by Product 43
4.2 Robotic Systems 45
4.3 Instruments and Accessories 46
4.4 System Services 47
5 Segmentation of Asia Pacific Market by Equipment Type 48
5.1 Market Overview by Equipment Type 48
5.2 Robot Machines 50
5.3 Navigation Systems 51
5.4 Planners and Simulators 52
5.5 Other Equipment Types 53
6 Segmentation of Asia Pacific Market by End User 54
6.1 Market Overview by End User 54
6.2 Hospitals 56
6.3 Ambulatory Surgical Centers 57
7 Asia-Pacific Market 2020-2027 by Country 58
7.1 Overview of Asia-Pacific Market 58
7.2 China 61
7.3 Japan 63
7.4 India 66
7.5 Australia 68
7.6 South Korea 70
7.7 Rest of APAC Region 72
8 Competitive Landscape 74
8.1 Overview of Key Vendors 74
8.2 New Product Launch, Partnership, Investment, and M&A 78
8.3 Company Profiles 79
Brainlab AG 79
DePuy Synthes (Johnson & Johnson) 81
Mazor Robotics Ltd. 84
Medtronic Inc. 85
Renishaw plc 88
Shenzhen Institutes of Advanced Technology (SIAT) 90
Siemens Healthineers 91
Simbionix USA Corp. 93
SONOWAND AS 95
Stryker Corp. / MAKO 96
Synaptive Medical, Inc. 100
Zimmer Biomet Holdings, Inc. / Medtech 101
9 Investing in Asia Pacific Market: Risk Assessment and Management 104
9.1 Risk Evaluation of Asia Pacific Market 104
9.2 Critical Success Factors (CSFs) 107
RELATED REPORTS 110